VPTDF

PINK Ventripoint Diagnostics Ltd.
Oct 21, 2026 · 5:49 PM ET LAST TRADE Market Closed

$0.0678 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0678, and at the day’s high of $0.0678

YTD change
-35.12%
vs 20-day SMA
+9.94%
vs 200-day SMA
-17.62%

Price ranges

Previous day
$0.0606 $0.0678
open $0.0623 close $0.0676
+$0.0053 (+8.59%)
Today
$0.0653 $0.0678
open $0.0677 now $0.0678
+$0.0001 (+0.15%)
Past week
$0.0556 $0.0678
from $0.0611 now $0.0678
+$0.0067 (+10.97%)
Past month
$0.0556 $0.0678
from $0.0646 now $0.0678
+$0.0032 (+4.92%)
This year
$0.0556 $0.1367
from $0.1045 now $0.0678
-$0.0367 (-35.12%)

Price & Performance

-0.02 (-19.04%) / 6M

$0.0528$0.0803$0.1078$0.1353Apr 21Jul 22Oct 20

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 87.7% away from all-time highs of $0.5500
  • VPTDF is down 35% since the beginning of the year
  • VPTDF is down 15% over the past 12 months
  • VPTDF is up 5% over the past 1 month
  • 0% of all VPTDF investors are betting against VPTDF

VPTDF reads very good: price sits above one of the two key moving averages, the 12-month move is -15.5%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0008
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $14.2M
Beta 0.20

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$235.2K
Debt$1.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $13.1M

VentriPoint Diagnostics Ltd. is a medical device company, which engages in the development and commercialization of diagnostic tools that monitor patients with heart disease. Its Ventripoint Medical System produces critical heart information by processing standard information received from existing medical imaging equipment with its patented and proprietary methods incorporating Knowledge Based Reconstruction algorithms and proprietary cardiac databases. The company was founded by Joseph Ashley and Florence H. Sheehan on May 4, 2005 and is headquartered in Toronto, Canada.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $33.05 +2.13%
BDX Becton, Dickinson and Company $193.80 +1.60%
DXCM DexCom, Inc. $85.74 -0.28%
MDLN Medline, Inc. Class A $35.46 +0.77%
WST West Pharmaceutical Services, Inc. $388.78 +1.27%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.